5-year survival
• All HNRMS
both cohorts:
FFS: 58.2% and OS: 76.0%
• EBRT-based
:
FFS: 63.8% and OS: 75.0%
• AMORE-based
FFS: 53.2% and OS: 76.9%
• (p = 0.37 and p = 0.56)
Failure-free survival
Overall survival